How to buy Quest Diagnostics Incorporated (DGX) stocks

Quest Diagnostics Incorporated is a diagnostics & research business based in the US. Quest Diagnostics Incorporated shares (DGX) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $153.10 – a decrease of 1.23% over the previous week. Quest Diagnostics Incorporated employs 50,000 staff and has a trailing 12-month revenue of around $9.5 billion.

Our top picks for where to buy Quest Diagnostics Incorporated stock

Buy Quest Diagnostics Incorporated stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Quest Diagnostics Incorporated stock price (NYSE: DGX)

Use our graph to track the performance of DGX stocks over time.

Quest Diagnostics Incorporated stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$153.10
52-week range	$121.09 - $165.32
50-day moving average more info button	$156.52
200-day moving average more info button	$145.43
Wall St. target price	$169.77
PE ratio more info button	20.3293
Dividend yield more info button	$2.96 (1.98%)
Earnings per share (TTM) more info button	$7.44

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Quest Diagnostics Incorporated price performance over time

Historical closes compared with the close of $153.1 from 2024-12-20

1 week (2024-12-13)	-1.23%
1 month (2024-11-22)	-6.41%
3 months (2024-09-20)	0.07%
6 months (2024-06-21)	10.18%

1 year (2023-12-22)	11.96%
2 years (2022-12-22)	2.56%
3 years (2021-12-22)	157.0648
5 years (2019-12-20)	58.99%

Is Quest Diagnostics Incorporated stock undervalued or overvalued?

Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Quest Diagnostics Incorporated's P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Quest Diagnostics Incorporated shares trade at around 20x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

Quest Diagnostics Incorporated's PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8113. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Quest Diagnostics Incorporated's EBITDA

Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.8 billion.

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

Quest Diagnostics Incorporated financials

Revenue TTM	$9.5 billion
Operating margin TTM	14.19%
Gross profit TTM	$3.5 billion
Return on assets TTM	5.66%
Return on equity TTM	13.22%
Profit margin	8.82%
Book value	$60.80
Market Capitalization more info button	$16.9 billion

TTM: trailing 12 months

Quest Diagnostics Incorporated's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Quest Diagnostics Incorporated's total ESG risk score

Total ESG risk: 18.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 12/31/2018) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Quest Diagnostics Incorporated's environmental score

Environmental score: 0.86/100

Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's social score

Social score: 10.42/100

Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Quest Diagnostics Incorporated's governance score

Governance score: 5.77/100

Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Quest Diagnostics Incorporated's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Quest Diagnostics Incorporated was last rated for ESG on: 2019-01-01.

Total ESG score	18.33
Total ESG percentile	16.26
Environmental score	0.86
Environmental score percentile	1
Social score	10.42
Social score percentile	1
Governance score	5.77
Governance score percentile	1
Level of controversy	3

Quest Diagnostics Incorporated stock dividends

Dividend payout ratio: 33.94% of net profits

Recently Quest Diagnostics Incorporated has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.96 per share.

While Quest Diagnostics Incorporated's payout ratio might seem fairly standard, it's worth remembering that Quest Diagnostics Incorporated may be investing much of the rest of its net profits in future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 28 January 2025. The latest dividend was paid out to all shareholders who bought their stocks by 13 January 2025 (the "ex-dividend date").

Have Quest Diagnostics Incorporated's stocks ever split?

Quest Diagnostics Incorporated's stocks were split on a 2:1 basis on 20 June 2005 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for Quest Diagnostics Incorporated stocks, which in turn could have impacted Quest Diagnostics Incorporated's stock price.

Quest Diagnostics Incorporated stock price volatility

Over the last 12 months, Quest Diagnostics Incorporated's stocks have ranged in value from as little as $121.085 up to $165.32. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 0.891. This would suggest that Quest Diagnostics Incorporated's stocks are less volatile than average (for this exchange).

Quest Diagnostics Incorporated overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Quest Diagnostics Incorporated is owned by insiders or institutions?
Currently 0.43% of Quest Diagnostics Incorporated stocks are held by insiders and 91.563% by institutions. How many people work for Quest Diagnostics Incorporated?
Latest data suggests 50,000 work at Quest Diagnostics Incorporated. When does the fiscal year end for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated's fiscal year ends in December. Where is Quest Diagnostics Incorporated based?
Quest Diagnostics Incorporated's address is: 500 Plaza Drive, Secaucus, NJ, United States, 07094 What is Quest Diagnostics Incorporated's ISIN number?
Quest Diagnostics Incorporated's international securities identification number is: US74834L1008 What is Quest Diagnostics Incorporated's CUSIP number?
Quest Diagnostics Incorporated's Committee on Uniform Securities Identification Procedures number is: 74834L100

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.